| Heterogeneity versus homogeneity of multiple sclerosis. | |
| | |
MedLine Citation:
|
PMID: 21426254 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The 10th International Congress of Neuroimmunology, including the 10th European School of Neuroimmunology Course, was held by the International Society of Neuroimmunology in Sitges (Barcelona, Spain) on 26-30 October 2010. The conference covered a wide spectrum of issues and challenges in both basic science and clinical aspects of neuroimmunology. Data and ideas were shared through a variety of programs, including review talks and poster sessions. One of the topics of the congress was whether multiple sclerosis is a homogenous or heterogenous disease, clinically and pathologically, throughout its course. |
| | |
Authors:
|
Fumitaka Sato; Nicholas E Martinez; Seiichi Omura; Ikuo Tsunoda |
Related Documents
:
|
21187834 - Editorial - toxcon 2010. 13962884 - Some observations on the cholera (e1 tor) epidemic in 1961-62. 21779694 - Malaria epidemics in europe after the first world war: the early stages of an internati... 19684374 - Homage to robert hooke (1635-1703): new insights from the recently discovered hooke folio. 15706724 - New paths of medical ethics. 15592254 - Ethics committees in long-term care facilities. |
Publication Detail:
|
Type: Congresses |
Journal Detail:
|
Title: Expert review of clinical immunology Volume: 7 ISSN: 1744-8409 ISO Abbreviation: Expert Rev Clin Immunol Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-03-23 Completed Date: 2011-07-26 Revised Date: 2011-07-28 |
Medline Journal Info:
|
Nlm Unique ID: 101271248 Medline TA: Expert Rev Clin Immunol Country: England |
Other Details:
|
Languages: eng Pagination: 165-7 Citation Subset: IM |
Affiliation:
|
Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antibodies, Monoclonal / pharmacology, therapeutic use B-Lymphocytes / drug effects*, immunology Clinical Trials as Topic Disease Progression Humans Immunotherapy* Lymphocyte Depletion Models, Animal Multiple Sclerosis, Chronic Progressive / immunology*, physiopathology, therapy Multiple Sclerosis, Relapsing-Remitting / immunology*, physiopathology, therapy Neuritis Neuroimmunomodulation Spain T-Lymphocyte Subsets / drug effects*, immunology |
| Grant Support | |
ID/Acronym/Agency:
|
P20 RR018724-08/RR/NCRR NIH HHS; R21 NS059724-03/NS/NINDS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ustekinumab for the treatment of psoriasis.
Next Document: DNA double-strand break repair, immunodeficiency and the RIDDLE syndrome.